Home/Filings/4/0001209191-22-055877
4//SEC Filing

Zaks Tal Zvi 4

Accession 0001209191-22-055877

CIK 0000818686other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 7:02 AM ET

Size

7.4 KB

Accession

0001209191-22-055877

Insider Transaction Report

Form 4
Period: 2022-11-04
Zaks Tal Zvi
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-11-04+12,20512,222 total
  • Exercise/Conversion

    Restricted Share Units

    2022-11-0412,2050 total
    Ordinary Shares (12,205 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on November 4, 2021 and vested on November 4, 2022.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001690927

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 7:02 AM ET
Size
7.4 KB